Kenvue Inc.
KVUE
Classement en actions
#657
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Prix de l'action
$19.06
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$36.60B
Changement (1 jour)
-1.22%
Changement (1 an)
25.44%
Pays
US
Échange Kenvue Inc. (KVUE)
Catégorie
Consumer Defensive
Revenus pour Kenvue Inc. (KVUE)
Revenus en Jun 2026 TTM : $15.41B
Selon les derniers rapports financiers de Kenvue Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de $15.41B. En 2023, l'entreprise a réalisé un chiffre d'affaires de $15.44B une augmentation par rapport à le chiffre d'affaires de l'année 2022, qui était de $14.95B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Kenvue Inc. de 2019 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $15.41B | -0.30% |
| 2024 | $15.46B | 0.07% |
| 2023 | $15.44B | 3.30% |
| 2022 | $14.95B | -0.69% |
| 2021 | $15.05B | 4.06% |
| 2020 | $14.47B | 1.00% |
| 2019 | $14.32B | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $87.03B | 464.85% |
US
|
|
| $51.67B | 235.32% |
FR
|
|
| $21.05B | 36.59% |
US
|
|
| $7.28B | -52.72% |
IN
|
|
| $15.05B | -2.33% |
US
|
